Personal information

No personal information available

Activities

Collapse all

Employment (1)

Guangdong Provincial People's Hospital: Guangzhou, CN

2005-07-01 to present
Employment
Source: Self-asserted source
Kun Wang

Education and qualifications (3)

Sun Yat-Sen University: Guangzhou, Guangdong, CN

2002 to 2005
Qualification
Source: Self-asserted source
Kun Wang

Wuhan University : Wuhan, Hubei, CN

1996-09-01 to 1999-07-01
Qualification
Source: Self-asserted source
Kun Wang

Wuhan University: Wuhan, Hubei, CN

1989 to 1994
Qualification
Source: Self-asserted source
Kun Wang

Works (50 of 54)

Items per page:
Page 1 of 2

Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer

Journal of Breast Cancer
2024 | Journal article
DOI: 10.4048/jbc.2023.0136
Contributors: Jiachen Zou; Liulu Zhang; Yuanqi Chen; Yingyi Lin; Minyi Cheng; Xingxing Zheng; Xiaosheng Zhuang; Kun Wang
Source: check_circle
Crossref

MRI-based artificial intelligence models for post-neoadjuvant surgery personalization in breast cancer: a narrative review of evidence from Western Pacific

The Lancet Regional Health - Western Pacific
2024-12 | Journal article
DOI: 10.1016/j.lanwpc.2024.101254
Contributors: Yingyi Lin; Minyi Cheng; Cangui Wu; Yuhong Huang; Teng Zhu; Jieqing Li; Hongfei Gao; Kun Wang
Source: check_circle
Crossref

A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial

British Journal of Cancer
2024-09-07 | Journal article | Author
DOI: 10.1038/s41416-024-02726-3
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Contributors: Teng Zhu; Yu-Hong Huang; Wei Li; Can-Gui Wu; Yi-Min Zhang; Xing-Xing Zheng; Ting-Feng Zhang; Ying-Yi Lin; Zai-Yi Liu; Guo-Lin Ye et al.
Source: Self-asserted source
Kun Wang

Clinical efficacy of tumor organoid‐guided cancer therapy for locally advanced unresectable or metastatic breast cancer

International Journal of Cancer
2024-08-15 | Journal article | Author
DOI: 10.1002/ijc.34945
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Contributors: Ying‐yi Lin; Hong‐fei Gao; Hong Li; Qiong Hu; Bo‐le Du; Sheng Li; Fang‐ping Xu; Min‐yi Cheng; Jia‐chen Zou; Xing‐xing Zheng et al.
Source: Self-asserted source
Kun Wang

Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy

Supportive Care in Cancer
2024-06 | Journal article
DOI: 10.1007/s00520-024-08610-3
Contributors: Ciqiu Yang; Peiyong Li; Yitian Chen; Junqiu Zheng; Xiaoqi Zhang; Hong-Fei Gao; Liulu Zhang; Kun Wang
Source: check_circle
Crossref

Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden during Neoadjuvant Chemotherapy in Breast Cancer

Annals of Surgery
2024-04-01 | Journal article
DOI: 10.1097/sla.0000000000006279
Part of ISSN: 0003-4932
Contributors: Wei Li; Yu-Hong Huang; Teng Zhu; Yi-Min Zhang; Xing-Xing Zheng; Ting-Feng Zhang; Ying-Yi Lin; Zhi-Yong Wu; Zai-Yi Liu; Ying Lin et al.
Source: Self-asserted source
Kun Wang

18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer

EJNMMI Research
2023-12-06 | Journal article
DOI: 10.1186/s13550-023-01053-7
Contributors: Xingxing Zheng; Yuhong Huang; Yingyi Lin; Teng Zhu; Jiachen Zou; Shuxia Wang; Kun Wang
Source: check_circle
Crossref

Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study

International Journal of Surgery
2023-11 | Journal article
DOI: 10.1097/js9.0000000000000621
Part of ISSN: 1743-9159
Contributors: Teng Zhu; Yu-Hong Huang; Wei Li; Yi-Min Zhang; Ying-Yi Lin; Min-Yi Cheng; Zhi-Yong Wu; Guo-Lin Ye; Ying Lin; Kun Wang
Source: Self-asserted source
Kun Wang

Survival differences between HER2-0 and HER2-low-expressing breast cancer − A meta-analysis of early breast cancer patients

Critical Reviews in Oncology/Hematology
2023-05 | Journal article
DOI: 10.1016/j.critrevonc.2023.103962
Contributors: Ciqiu Yang; Xiaoqi Zhang; Yitian Chen; Peiyong Li; Junsheng Zhang; Aiqi Xu; Na Huang; Minting Liang; Yilin Chen; Kun Wang
Source: check_circle
Crossref

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study

eClinicalMedicine
2023-04 | Journal article | Author
DOI: 10.1016/j.eclinm.2023.101899
Part of ISSN: 2589-5370
Contributors: YuHong Huang; Teng Zhu; XiaoLing Zhang; Wei Li; XingXing Zheng; MinYi Cheng; Fei Ji; LiuLu Zhang; CiQiu Yang; ZhiYong Wu et al.
Source: Self-asserted source
Kun Wang

Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population‐based study

Cancer Medicine
2023-03 | Journal article
DOI: 10.1002/cam4.5425
Contributors: Bo Shen; Jieqing Li; Mei Yang; Kangkang Liu; Junsheng Zhang; Weiping Li; Yi Zhang; Kun Wang
Source: check_circle
Crossref

Ceramide kinase confers tamoxifen resistance in estrogen receptor-positive breast cancer by altering sphingolipid metabolism

Pharmacological Research
2023-01 | Journal article
DOI: 10.1016/j.phrs.2022.106558
Part of ISSN: 1043-6618
Contributors: Cheng Huang; Liangping Su; Yitian Chen; Sangqing Wu; Ruipu Sun; Qiuping Xu; Xiaoyi Qiu; Ciqiu Yang; Xiangzhan Kong; Hongquan Qin et al.
Source: Self-asserted source
Kun Wang

Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis

The Breast
2022-12 | Journal article
DOI: 10.1016/j.breast.2022.08.006
Part of ISSN: 0960-9776
Contributors: Kun Wang
Source: Self-asserted source
Kun Wang

Ultrasound-assisted carbon nanoparticle suspension mapping <i>versus</i> dual tracer-guided sentinel lymph node biopsy in patients with early breast cancer (ultraCars): phase III randomized clinical trial

British Journal of Surgery
2022-09-08 | Journal article
DOI: 10.1093/bjs/znac311
Part of ISSN: 0007-1323
Part of ISSN: 1365-2168
Contributors: Kun Wang
Source: Self-asserted source
Kun Wang
grade
Preferred source (of 2)‎

Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial

European Journal of Cancer
2022-08 | Journal article
DOI: 10.1016/j.ejca.2022.05.019
Part of ISSN: 0959-8049
Source: Self-asserted source
Kun Wang

The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs

Frontiers in Immunology
2022-08-31 | Journal article
DOI: 10.3389/fimmu.2022.982486
Part of ISSN: 1664-3224
Contributors: Kun Wang
Source: Self-asserted source
Kun Wang

Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs

Phytotherapy Research
2022-06 | Journal article
DOI: 10.1002/ptr.7515
Part of ISSN: 0951-418X
Part of ISSN: 1099-1573
Source: Self-asserted source
Kun Wang

Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in <scp>triple‐negative</scp> , <scp>early‐stage</scp> breast cancer ( <scp>NeoCART</scp> ): Results from a multicenter, randomized controlled, <scp>open‐label</scp> phase <scp>II</scp> trial

International Journal of Cancer
2022-02-15 | Journal article
DOI: 10.1002/ijc.33830
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Source: Self-asserted source
Kun Wang

Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis

Therapeutic Advances in Medical Oncology
2022-01 | Journal article
DOI: 10.1177/17588359221096253
Contributors: Liulu Zhang; Yuanqi Chen; Min-Yi Cheng; Xiaosheng Zhuang; Jiachen Zou; Dannuo Wei; Ying-Yi Lin; Yi Zhang; Kun Wang
Source: check_circle
Crossref

Low-dose apatinib combined with neoadjuvant chemotherapy in the treatment of early-stage triple-negative breast cancer (LANCET): a single-center, single-arm, phase II trial

Therapeutic Advances in Medical Oncology
2022-01 | Journal article
DOI: 10.1177/17588359221118053
Part of ISSN: 1758-8359
Part of ISSN: 1758-8359
Contributors: Kun Wang
Source: Self-asserted source
Kun Wang
grade
Preferred source (of 2)‎

A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases

Disease Markers
2021-11-22 | Journal article
DOI: 10.1155/2021/7879508
Part of ISSN: 1875-8630
Part of ISSN: 0278-0240
Source: Self-asserted source
Kun Wang

Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials

The Breast
2021-10 | Journal article
DOI: 10.1016/j.breast.2021.07.002
Part of ISSN: 0960-9776
Source: Self-asserted source
Kun Wang
grade
Preferred source (of 2)‎

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures

Frontiers in Molecular Biosciences
2021-10-11 | Journal article
DOI: 10.3389/fmolb.2021.759495
Part of ISSN: 2296-889X
Source: Self-asserted source
Kun Wang

Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the Literature

Frontiers in Endocrinology
2021-10-08 | Journal article
DOI: 10.3389/fendo.2021.659537
Part of ISSN: 1664-2392
Source: Self-asserted source
Kun Wang

Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients

The Breast
2021-08 | Journal article
DOI: 10.1016/j.breast.2021.03.010
Part of ISSN: 0960-9776
Source: Self-asserted source
Kun Wang

SWIM domain protein ZSWIM4 is required for JAK2 inhibition resistance in breast cancer

Life Sciences
2021-08 | Journal article
DOI: 10.1016/j.lfs.2021.119696
Part of ISSN: 0024-3205
Source: Self-asserted source
Kun Wang

DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations

eBioMedicine
2021-07 | Journal article
DOI: 10.1016/j.ebiom.2021.103446
Part of ISSN: 2352-3964
Source: Self-asserted source
Kun Wang

Effects of Surgery on Prognosis of Young Women With Operable Breast Cancer in Different Marital Statuses: A Population-Based Cohort Study

Frontiers in Oncology
2021-06-23 | Journal article
DOI: 10.3389/fonc.2021.666316
Part of ISSN: 2234-943X
Source: Self-asserted source
Kun Wang

Anthracycline-containing <i>versus</i> carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial

Therapeutic Advances in Medical Oncology
2021-01 | Journal article
DOI: 10.1177/17588359211009003
Part of ISSN: 1758-8359
Part of ISSN: 1758-8359
Source: Self-asserted source
Kun Wang

Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis

The Breast
2020-12 | Journal article
DOI: 10.1016/j.breast.2020.09.003
Part of ISSN: 0960-9776
Source: Self-asserted source
Kun Wang
grade
Preferred source (of 2)‎

Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database

Frontiers in Oncology
2020-12-22 | Journal article
DOI: 10.3389/fonc.2020.590643
Part of ISSN: 2234-943X
Source: Self-asserted source
Kun Wang

A nomogram to predict non–sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy

Journal of Surgical Oncology
2020-09 | Journal article
DOI: 10.1002/jso.25989
Contributors: Minyi Cheng; Xiaosheng Zhuang; Liulu Zhang; Teng Zhu; Yufeng Lin; Mei Yang; Fei Ji; Ciqiu Yang; Hongfei Gao; Kun Wang
Source: check_circle
Crossref

A Nomogram to Predict Breast Tumor Regression Patterns after Neoadjuvant Chemotherapy Based on Baseline Characteristics

2020-08-14 | Other
DOI: 10.21203/rs.3.rs-57234/v1
Contributors: Xiaosheng Zhuang; Minyi Cheng; Liulu Zhang; Fei Ji; Teng Zhu; Ciqiu Yang; Mei Yang; Hongfei Gao; Jieqing Li; Kun Wang
Source: check_circle
Crossref

Risk of breast cancer-related death in women with a prior cancer

Aging
2020-04-06 | Journal article
DOI: 10.18632/aging.102984
Part of ISSN: 1945-4589
Source: Self-asserted source
Kun Wang

The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis

Therapeutic Advances in Medical Oncology
2020-01 | Journal article
DOI: 10.1177/1758835920958358
Part of ISSN: 1758-8359
Part of ISSN: 1758-8359
Source: Self-asserted source
Kun Wang

The Role of Sharp Dissection in Nipple-Sparing Mastectomy: A Safe Procedure with No Necrosis of the Nipple-Areolar Complex.

Cancer management and research
2019-12-04 | Journal article
DOI: 10.2147/CMAR.S230787
PMID: 31824192
PMC: PMC6900313
Source: Self-asserted source
Kun Wang

Mammography-based radiomic analysis for predicting benign BI-RADS category 4 calcifications.

European journal of radiology
2019-10-20 | Journal article
DOI: 10.1016/j.ejrad.2019.108711
PMID: 31677544
Source: Self-asserted source
Kun Wang

Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2019-04-11 | Journal article
DOI: 10.1007/s12094-019-02109-8
PMID: 30977048
Source: Self-asserted source
Kun Wang

Tumor location of the central and nipple portion is associated with impaired survival for women with breast cancer.

Cancer management and research
2019-04-09 | Journal article
DOI: 10.2147/CMAR.S186205
PMID: 31040717
PMC: PMC6461001
Source: Self-asserted source
Kun Wang

A breast one-patient panel of heterogeneous genomes reveals genetic alterations driving DCIS into invasive lesions.

Future oncology (London, England)
2019-03-19 | Journal article
DOI: 10.2217/fon-2018-0555
PMID: 30888194
Source: Self-asserted source
Kun Wang

Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study.

Clinical cancer research : an official journal of the American Association for Cancer Research
2019-03-06 | Journal article
DOI: 10.1158/1078-0432.ccr-18-3190
PMID: 30842125
Source: Self-asserted source
Kun Wang

Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases.

Breast cancer research and treatment
2019-02-02 | Journal article
DOI: 10.1007/s10549-019-05148-5
PMID: 30712197
Source: Self-asserted source
Kun Wang

Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study.

Journal of breast cancer
2019-02-02 | Journal article
DOI: 10.4048/jbc.2019.22.e10
PMID: 30941240
PMC: PMC6438836
Source: Self-asserted source
Kun Wang
grade
Preferred source (of 2)‎

Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis.

Journal of breast cancer
2018-08-28 | Journal article
DOI: 10.4048/jbc.2018.21.e36
PMID: 30275861
PMC: PMC6158154
Source: Self-asserted source
Kun Wang

Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study.

World journal of surgical oncology
2018-06-19 | Journal article
DOI: 10.1186/s12957-018-1414-6
PMID: 29914538
PMC: PMC6006710
Source: Self-asserted source
Kun Wang

Prognostic Significance of Mesenchymal-Epithelial Transition in Triple-Negative Breast Cancers.

Clinical breast cancer
2018-05-07 | Journal article
DOI: 10.1016/j.clbc.2018.04.021
PMID: 29880407
Source: Self-asserted source
Kun Wang

An obligatory anaerobic Salmonella typhimurium strain redirects M2 macrophages to the M1 phenotype.

Oncology letters
2018-01-08 | Journal article
DOI: 10.3892/ol.2018.7742
PMID: 29456740
PMC: PMC5795882
Source: Self-asserted source
Kun Wang

Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.

Journal of magnetic resonance imaging : JMRI
2017-11-22 | Journal article
DOI: 10.1002/jmri.25904
PMID: 29165847
Source: Self-asserted source
Kun Wang

Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines.

Breast cancer research and treatment
2017-08-31 | Journal article
DOI: 10.1007/s10549-017-4479-y
PMID: 28861637
Source: Self-asserted source
Kun Wang

Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy.

Oncotarget
2017-07-28 | Journal article
DOI: 10.18632/oncotarget.19686
PMID: 29254147
PMC: PMC5731857
Source: Self-asserted source
Kun Wang
Items per page:
Page 1 of 2

Peer review (1 review for 1 publication/grant)

Review activity for Neoplasia. (1)
How many people are using ORCID?